Clear, a spun-out of VC Antler, is a healthtech startup that measures blood glucose levels in real-time using a chip-implanted arm patch and an app.
Clear's ambition is to help billions of people with a healthier lifestyle through the right food choices: preventively but also as support in current treatment.
Clear was founded in 2019 by Piet Hein van Dam and Madelon Bracke. The company is headquartered in Amsterdam, Netherlands.
Clear.bio has developed a digital self-help tool that helps users put together a fully personalised diet and follow it in their daily lives. It offers a health programme based on a personal glucose metre, an app, a proprietary glucose algorithm and an AI food recommender.
Clear, through a sensor and an app, analyzes blood glucose levels to detect individual reactions to food. It then provides users with personalized advice in real-time. It then provides users with personalized advice in real-time.
Clear is backed by Antler VC, Rabobank, Mustard Seed Maze, Healthy.Capital, Future Food Fund, Achmea Innovation Fund, and others. The company raised a new financing of an undisclosed amount on Nov 09, 2022. Clear.bio has raised a total of €2.9M in funding to date.
